According to Bliss GVS Pharma latest financial reports the cash on hand of BLISSGVS is $8.16M, an decrease of -49.33% to 2022. At the end of 2022 company had $16.10M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $8.16M | -49.33% |
2022 | $16.10M | 73.57% |
2021 | $9.27M | 94.59% |
2020 | $4.77M | -53.98% |
2019 | $10.36M | - |